Back to search results

Study on Enhanced Music & Natural Visuals for Emotional Health

This study is exploring how a software application called soundBrilliance, which uses enhanced music, natural visuals, and spoken guidance, might help improve emotional health. Researchers want to see if using this app for at least 4 days a week over 12 weeks can help people manage their emotions better. You might be able to join if you are 13 years or older, can read and write English, and are willing to participate in the study activities. Success in this study will be measured by changes in your anxiety levels, mood, and overall emotional well-being, as reported through questionnaires over the 12-week period. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 200 participants. It will compare a treatment group using the soundBrilliance app to a control group.
What's involved
You would use the soundBrilliance app for at least 4 days a week over 12 weeks. You would also complete questionnaires at the beginning and every two weeks for 12 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your emotional health will be monitored for 12 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07676110

The Impact of Enhanced Music & Natural Visuals on Emotional Health

Recruiting
NAAges 13+InterventionalTreatment
soundBrilliance LLC
~200 participants
Updated 2026-06-30 on ClinicalTrials.gov
What's tested:soundBrilliance software application - Emotional Health

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in State Trait Anxiety Inventory - State (STAI-S) between treatment vs control groups.
Measured over Baseline and at 2-week intervals over the duration of 12-week protocol (0, 2, 4, 6, 8, 10, 12 weeks post-baseline).
+2 more outcomes measured

Conditions

Emotion Management Skills
Lifestyle, Healthy
Lifestyle Intervention
Recovery
Exercise and Recovery
Exercise Training
Anxiety and Mood Disorders
Sleep
Motivation
Comfort
Pain Management
Rehabilitation
Creativity and Mindfulness

Explore related trials

Anxiety and Mood Disorders

Where it's being run

3 sites across 3 states
Colorado1
Nebraska1
Nevada1

Study leadership

  • Jason S Doescher, MD · PRINCIPAL_INVESTIGATOR · soundBrilliance LLC

Who to contact

Robert Mele (VP of Clinical Research & Testing Operations), B.Eng
[email protected]
7752444866 · ext. 1
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

You are 13 years of age or older
You can read, write, and speak English at a 5th-grade level or higher
You are legally capable of providing informed consent (adult participants) or capable of providing assent (child participants)
To the best of your knowledge, you are willing and able to commit to the session(s) and activities of this study
You are willing and able to use the sound-delivery and data-collection apparatus of this study
You are willing to use your own personal equipment. Depending on the study, you may need to have your own ear buds/headphones and/or a "smart" device with internet and/or Bluetooth access (e.g., smartphone, iPad).
You have normal hearing in both ears.
You never experience ringing noises or buzzing sensations in your ears (tinnitus)
You do not use a heart/cardiac pacemaker and do not have any history of cardiac rhythm disturbances, such as cardiac conduction delays or blocks
You have no known history of fainting, fainting, spells or seizures, spinning sensations, or trouble with balance (medical terms include epilepsy, seizures, syncope, vertigo, nystagmus)
You do not use of any of the following medications: Beta blockers, steroids, ephedrine, acute anti-anxiety medication (e.g., benzodiazepines such as diazepam/Valium, lorazepam/Ativan or clonazepam/Klonopin), or acute or chronic pain medications (including narcotics and codeine)
For any study session, you will not be under the influence of any substances that could prevent safe participation and will not have consumed e.g., alcohol, THC, Psilocybin, or other mood-altering drugs in the 12 hours preceding the session.

What this trial measures

  • Change in State Trait Anxiety Inventory - State (STAI-S) between treatment vs control groups.Baseline and at 2-week intervals over the duration of 12-week protocol (0, 2, 4, 6, 8, 10, 12 weeks post-baseline).

    The 20 item STAI-S, a self-report survey reflecting current symptoms of anxiety, will be given to both groups at baseline and at 2-week intervals through the duration of the 12-week protocol. The difference in group mean change of STAI-S from baseline across 2-week milestones will be estimated.

  • Change in Patient Health Questionnaire (8 question; PHQ-8) between treatment vs control groups.Baseline and at 2-week intervals over the duration of the 12-week protocol (0, 2, 4, 6, 8, 10, 12-week post-baseline).

    The 8 item PHQ-8, a self-report survey reflecting current symptoms of depression, will be given to both groups at baseline and at 20week intervals through the duration of the 12-week protocol. The difference in group mean change of PHQ-8 from baseline across 2-week milestones will be estimated.

  • Change in Positive and Negative Affect Schedule (20 item; PANAS-SF) between treatment vs control groups.Baseline and at 2-week intervals over the duration of 12-week protocol (0, 2, 4, 6, 8, 10, 12 weeks post-baseline).

    The 20 item PANAS-SF will be given to both groups at baseline and at 2-week intervals through the duration of the 12-week protocol. The difference in group mean change of positive and negative affect scores from baseline across 2-week milestones will be estimated.